Established in consolidation of Taiwan’s biomedical development, the major objectives of the Incubation Center encompass fostering growth among innovative pharmaceutical businesses via networking and joint-venture opportunities, along with gaining access to invaluable R&D and marketing resources. This is all encapsulated in the global image of ‘BioHub Taiwan’ which we seek to promote. In addition to startups and small businesses we welcome the installation of mature firms as well. Vibrant interaction amid a diverse composition enables insight and experience to be exchanged; we look forward to the fruitful outcomes this environment shall spark. We also provide space and cooperation schemes for internationally leading accelerators to situate or extend themselves, and make most of what our country’s investors and venture capital funds have to offer.
- Cultivate more successful tales in Taiwan’s biotechnological and pharmaceutical industry
- Establish a core foundation Taiwan’s biotechnology and pharmaceutics.
- Enhance the value of Taiwan’s biotechnological and pharmaceutical industry.
- Invest into the development of Taiwan’s biotechnological and pharmaceutical industry.
MEET THE TEAM
Dr. Shih-Torng Ding
Dr. Stone Ding is a biotechnologist specialized in food producing animals. Acclaimed as one of the youngest and brightest researchers in Taiwan, Dr. Ding was selected as head of the National Taiwan University Biotechnology Center. His research findings are under translation to help humans cope with obesity and fatty livers. His creative abilities have led to him being awarded with several highly competitive, extramural funding grants. He was selected as the lead investigator on the successful Pan-Pacific Genome Proposal; from which he instituted a platform in development of an internationally recognized research program regarding the growth of food production animals, attainable by few worldwide. Recognized as an exceptional teacher at National Taiwan University, Dr. Ding’s success in enriching pupils with his own scientific and philosophical knowledge base has rendered him the Associate Director for the Center for Teaching and Learning at National Taiwan University.
- Deputy Executive Secretary, Board of Science and Technology, EY 2014-Now
- Distinguished Professor and Chair, Department of Animal Science and Technology, National Taiwan University, 2016-Now
- Coordinator of Agriculture Frontier Project, Ministry of Science and Technology, 2014-2016
- Co-Coordinator of Agriculture Resource Discipline, Ministry of Science and Technology, 2013-2015
- Director, Center of Biotechnology, National Taiwan University, 2009-2015
- Section Chief 0f Research and Development, Center of Biotechnology, National Taiwan University, 2006-2009
- Section Chief 0f Student Learning, Center of Teaching and Learning, National Taiwan University, 2006-2012
- Assistant to Associate Professor, Department of Animal Science and Technology, National Taiwan University, 2000-2006
- PostDoc Fellow, Baylor College of Medicine, 1996-2000
- PhD, Ohio State University, 1996
Dr. IC Jan
Assistant Chief ExecutiveIntroduction
Dr. I-Chien (IC) Jan joined NBRP around the end of 2017 as Assistant Chief Executive of BioHub to strengthen the biomedical startup ecosystem in Taiwan. Concentrated on fields of translational medicine and digital healthcare, Dr. Jan aspires to aid startups in ‘Arising Local and Advancing Global’. He has also served as Distinguished Research Fellow at BTDRL of ITRI, continually consulting startup teams on technical marketing and fundraising capabilities.
Prior to joining NBRP ITRI, Dr. Jan was co-founder and full-time partner of AppWorks Venture between 2010-2016. As Asia’s leading startup accelerator and most active early-stage VC, AppWorks and its renowned 6-month free program now admit 30 startups per batch across the region. 320 active startups and 720 founders make up its alumni network. An annual revenue of US$ 1.06 billion has been generated by all AppWorks startups together, along with 4,557 jobs whose value figure up to US$ 1.21 billion. With US$ 61 M under management, AppWorks funds 10 deals yearly, owns 40 companies within its portfolio, and has produced 2 IPOs thus far.
Between 2010 and 2012, Dr. Jan was VP & Acting CEO at ARDIC Instruments Co., a technology transformation and commercialization platform offering pipelines of analytical instruments in biotech and nanotech.
From 2007 to 2010, Dr. Jan was Director of Development Dept. at Chang-Yu Technology (CYT) and Vice President at OTO Science with a focus on miniature optical spectrometer based on MEMs technology.
From 2004 to 2007, Dr. Jan worked for top-tier biotech and IT venture funds including independent VC (ChengXin VC Group), Banking VC (Industrial Bank of Taiwan), and corporate VC (Harbinger Ventures of MiTAC/Synnex Group) in Taiwan. He received a doctoral degree in Biomedical Engineering from National Taiwan University (2004) and an MBA in intellectual Property from National Chengchi University (2009).
Dr. Rong-Jie Chen
Dr. Rong-Jie Chen is the Deputy Manager of BioHub Taiwan. He manages the situating of companies into NBRP, and assists Dr. Jan and Dr. Ding in their search for potential teams, startups, and innovative companies to establish a positive cycle among biomedical industries.
Dr. Chen boasts a rich, diverse work experience in Pharmaceutical and Cosmetic industries prior to joining BioHub. During his time as Associate Scientist at United Neuroscience (2015-2018), Dr. Chen conducted pre-clinical experiment test/ design, clinical examination development, and literary survey as part of neurodegenerative disease projects. He is well acquainted with biotech industry background and intellectual properties. His experience as product manager at Aesolution Biomedical (2015) had equipped him with a business skill set widely across strategic thinking, marketing, forecasting, P&L etc. Dr. Chen obtained his neurology-related doctoral degree from Genomics Research Center, Academia Sinica and National Defense Medical Center.
Ms. Yi-Shin Tsai is the Deputy Manager of BioHub Taiwan. She is responsible for the review process of tenancy applications into BioHub Taiwan at NBRP, as well as promotion and marketing affairs. She also assists Dr. Jan and Dr. Ding in their search for potential teams, startups, and innovative companies to establish a positive cycle among biomedical industries.
Ms. Tsai’s experiences prior to joining Biohub Taiwan ranges through Biotech-related industries and services: from IVD, health food ingredients, OEM and branding, to technology transfers; from which she is well-equipped with marketing capability. Ms. Tsai graduated with a master’s degree from the Institute of Zoology at National Taiwan University and now is studied another master’s in the Graduate Institute of Technology Innovation & Intellectual Property Management from National Chengchi University.
Dr. Bing-Hsien Liu
Dr. Bing-Hsien Liu is the Deputy Manager of BioHub Taiwan. He takes charge of the review process of tenancy applications into BioHub Taiwan at NBRP, and also assists Dr. Jan and Dr. Ding in their search for potential teams, startups, and innovative companies to establish a positive cycle among biomedical industries.
Dr. Liu had experience in IVD innovation company prior to joining BioHub Taiwan, and also as a post-doctoral researcher in the Institute of Polymer Science and Engineering at National Taiwan University. He was responsible for the development of neurodegenerative antibodies, ISO13485/ISO14971/GMP quality system and CE/IVD certification. He was project manager of Class III IVD clinical trial and TFDA registration as well as PI of several government funding & award applications, biomaterial and stem cells research. Dr. Liu has been recognized as an outstanding representative of the Biotechnology Talent Training and Employment Program (2014). He holds a molecular nutrition-related doctoral degree from the Department of Animal Science and Technology at National Taiwan University.
- 2014 – 2018 R & D Manager, MagQu Co., Ltd.
- 2013 – 2014 Researcher, Institute of Molecular and Cellular Biology, National Tsing Hua University, Taiwan
- 2010 – 2012 Post-doctoral researcher, Institute of Polymer Science and Engineering, National Taiwan University, Taiwan
- 2004 – 2009 Ph. D., Department of Animal Science and Technology, National Taiwan University, Taiwan
BioHub Taiwan occupies the first 3 floors of Building A and floors 2~8 of Building C in the NBRP. This includes 40 and 75 units respectively and amounts to 115 in total; each unit being around 165 square meters. Domestic companies, multinational corporations with an R&D base in Taiwan, and competent pre-startups are all eligible to apply; provided there is an R&D concentration in innovative drug development and smart healthcare. Beyond space provision, BioHub Taiwan fosters a setting wherein industry, academia, and research dynamics engage and excite one another. Our anticipation for the plentiful ideas and opportunities that shall arise from these interactions is embodied in an open plan design in lower Building C.
To simultaneously build an all-in-one service model assembling all information and resources from the government, BioHub has invited Biomedicine related agencies of the following: Biomedical Industry Innovation Promotion (BIIP) Program Office, Drug Commercialization Center (DCC), Medical Device Commercialization Center (MDDC), Biotechnology and Pharmaceutical Industries Promotion Office (BPIPO) and Center for Drug Evaluation (CDE) to form a joint office in advisory capacity. Our joint office shall propel the technological collaboration, regulatory coordination, and commercialization across departments within and without the NBRP to nurture the growth of biomedicine seedlings.